Related scientific articles (all)

Neoadjuvant anthracycline and trastuzumab for breast cancer: is concurrent treatment safe?

Authors : Bozovic-Spasojevic I, Azim HA, Paesmans M, Suter T, Piccart-Gebhart M, de Azambuja E
Year : 2011
Journal : Lancet Oncol
Volume : 12(3)
Pages : 209-11

Chromatin disruption in the promoter of bovine leukemia virus during transcriptional activation.

Authors : Colin L, Dekoninck A, Reichert M, Calao M, Merimi M, Van den Broeke A, Vierendeel V, Cleuter Y, Burny A, Rohr O, Van Lint C
Year : 2011
Journal : Nucleic Acids Res.
Volume : 39(22)
Pages : 9559-73

Perceptions of appropriateness of care among European and Israeli intensive care unit nurses and physicians.

Authors : Piers RD, Azoulay E, Ricou B, Dekeyser Ganz F, Decruyenaere J, Max A, Michalsen A, Maia PA, Owczuk R, Rubulotta F, Depuydt P, Meert AP, Reyners AK, Aquilina A, Bekaert M, Van den Noortgate NJ, Schrauwen WJ, Benoit DD
Year : 2011
Journal : JAMA
Volume : 306(24)
Pages : 2694-703

Treatment of metastatic breast cancer: state-of-the-art, subtypes and perspectives.

Authors : El Saghir NS, Tfayli A, Hatoum HA, Nachef Z, Dinh P, Awada A
Year : 2011
Journal : Crit Rev Oncol Hematol
Volume : 80(3)
Pages : 433-49

Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen : patient-level meta-analysis of randomized trials.(Early Breast Cancer Trialists’ Collaborative Group (Ebctcg))

Authors : Davies C, Godwin J, Gray R, Clarke M, Cutter D, Darby S, Mcgale P, Pan HC, Taylor C, Wang YC, Dowsett M, Ingle J, Peto R
Year : 2011
Journal : Lancet
Volume : 378 (9793)
Pages : 771-84

Multifactorial approach to predicting resistance to anthracyclines.

Authors : Desmedt C, Di Leo A, de Azambuja E, Larsimont D, Haibe-Kains B, Selleslags J, Delaloge S, Duhem C, Kains JP, Carly B, Maerevoet M, Vindevoghel A, Rouas G, Lallemand F, Durbecq V, Cardoso F, Salgado R, Rovere R, Bontempi G, Michiels S, Buyse M, Nogaret JM, Qi Y, Symmans F, Pusztai L
Year : 2011
Journal : J. Clin. Oncol.
Volume : 29(12)
Pages : 1578-86

Carcinoma in situ at the bronchial resection margin: a review.

Authors : Vallières E, Van Houtte P, Travis WD, Rami-Porta R, Goldstraw P
Year : 2011
Journal : J Thorac Oncol
Volume : 6(10)
Pages : 1617-23

Differentiation associated regulation of microRNA expression in vivo in human CD8+ T cell subsets.

Authors : Salaun B, Yamamoto T, Badran B, Tsunetsugu-Yokota Y, Roux A, Baitsch L, Rouas R, Fayyad-Kazan H, Baumgaertner P, Devevre E, Ramesh A, Braun M, Speiser D, Autran B, Martiat P, Appay V, Romero P
Year : 2011
Journal : J Transl Med
Volume : 9(null)
Pages : 44

Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death : meta-analysis of individual patient data for 10,801 women in 17 randomised trials.(Early Breast Cancer Trialists’ Collaborative Group (Ebct

Authors : Darby S, Mcgale P, Correa C, Taylor C, Arriagada R, Clarke M, Cutter D, Davies C, Ewertz M, Godwin J, Gray R, Pierce L, Whelan T, Wang Y, Peto R
Year : 2011
Journal : Lancet
Volume : 378 (9804)
Pages : 1707-16

Postoperative radiotherapy in non-small cell lung cancer.

Authors : Roelandts M, Moretti L, Van Houtte P
Year : 2011
Journal : Cancer Radiother
Volume : 15(6-7)
Pages : 514-7

Radiotherapy of lung cancer: Any room left for elective mediastinal irradiation in 2011?

Authors : Van Houtte P, Roelandts M, Mornex F
Year : 2011
Journal : Cancer Radiother
Volume : 15(6-7)
Pages : 509-13

Breast cancer: towards an evolution of minimalist locoregional therapy.

Authors : Nogaret JM
Year : 2011
Journal : Bull. Mem. Acad. R. Med. Belg.
Volume : 166(5-6)
Pages : 229-32; discussion 233-4

MLN8054, a small molecule inhibitor of aurora kinase a, sensitizes androgen-resistant prostate cancer to radiation.

Authors : Moretti L, Niermann K, Schleicher S, Giacalone NJ, Varki V, Kim KW, Kopsombut P, Jung DK, Lu B
Year : 2011
Journal : Int J Radiat Oncol Biol Phys
Volume : 80(4)
Pages : 1189-97

Long-term toxic effects of adjuvant chemotherapy in breast cancer.

Authors : Azim HA, de Azambuja E, Colozza M, Bines J, Piccart-Gebhart M
Year : 2011
Journal : Ann Oncol
Volume : 22(9)
Pages : 1939-47

Therapeutic advances in non-small cell lung cancer.

Authors : Vallières E, Peters S, Van Houtte P, Dalal P, Lim E
Year : 2011
Journal : Thorax
Volume : 67
Pages : 1097-101

An observational efficacy and safety analysis of the treatment of acute invasive aspergillosis using voriconazole.

Authors : Jacobs F, Selleslag D, Aoun M, Sonet A, Gadisseur A
Year : 2011
Journal : Eur J Clin Microbiol Infect Dis
Volume : 31(6)
Pages : 1173-9

Practical use of GenoType HelicoDR, a molecular test for Helicobacter pylori detection and susceptibility testing

Authors : Miendje Deyi VY, Burette A, Bentatou Z, Maaroufi Y, Bontems P, Lepage P, Reynders M
Year : 2011
Journal : Diagn Microbiol Infect Dis
Volume : 70(4)
Pages : 557-60

Beyond trastuzumab: new treatment options for HER2-positive breast cancer.

Authors : Saini KS, Azim HA, Metzger-Filho O, Loi S, Sotiriou C, de Azambuja E, Piccart-Gebhart M
Year : 2011
Journal : Breast
Volume : 20 Suppl 3
Pages : S20-7

New Imaging Techniques for 90Y Microsphere Radioembolization.

Authors : Vouche M, Vanderlinden B, Delatte P, Lemort M, Hendlisz A, Deleporte A, Garcia C, Flamen P
Year : 2011
Journal : J Nucl Med Radiat Ther
Volume : 2
Pages : 113

Proteomic changes associated with breast cancer progression in the MCF10AT model.

Authors : Fumagalli D, Michiels S, Sotiriou C
Year : 2011
Journal : Pharmacogenomics
Volume : 12(1)
Pages : 9-10